Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.
Journal: Cancer research
Published: March 10, 2026
Quantitative bias analyses to address measurement error in time-to-event endpoints.
Journal: American journal of epidemiology
Published: October 10, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.
Journal: Research square
Published: May 05, 2025
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.
Journal: Cancer research
Published: March 22, 2024
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2023
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
Journal: The Lancet. Haematology
Published: September 28, 2022
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 02, 2022
Last Updated: 09/26/2026